Publications by authors named "Saana V Luukkanen"
Article Synopsis
- Biological drugs are very expensive and critical for treating chronic diseases, but biosimilars, which are similar to these drugs, can help lower costs.
- The study focused on how the introduction of biosimilars in Finland between 2009 and 2020 affected the prices of original biological products and the overall competition in the biological drug market.
- Findings revealed that the prices of reference products usually decreased when biosimilars entered the market, while biosimilar prices remained relatively stable, highlighting their role in influencing healthcare costs.
